The document discusses a clinical trial sponsor providing an informed consent template for a new trial, with clinical investigators still responsible for ensuring the template meets ICH-GCP and FDA regulations. It also states that in the United States, Institutional Review Board oversight of participant safety and well-being in clinical trials is required by law.